Clinical management of a case of recurrent apocrine gland carcinoma of the scalp: Efficacy of a chemotherapy schedule with methotrexate and bleomycin

A. Morabito, P. Bevilacqua, S. Vitale, M. Fanelli, D. Gattuso, G. Gasparini

Research output: Contribution to journalArticle

Abstract

Apocrine carcinoma of the skin is a rare tumor. Wide surgical excision with complete removal of the neoplasm is the standard therapy and this appears to offer the best chance of cure. Radiotherapy may be used in case of local relapse or regional lymph node involvement. Systemic chemotherapy has not proved to be effective in the treatment of this tumor. We report on a 46-year-old woman with a recurrent apocrine carcinoma of the scalp that had previously been treated with surgery, radiotherapy and chemotherapy (Al-Saraff schedule). The patient was responsive to a second-line systemic chemotherapy regimen consisting of a weekly combination of methotrexate and bleomycin, and achieved long-term progression-free survival.

Original languageEnglish
Pages (from-to)472-474
Number of pages3
JournalTumori
Volume86
Issue number6
Publication statusPublished - 2000

Keywords

  • Apocrine carcinoma
  • Chemotherapy
  • Outcome

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical management of a case of recurrent apocrine gland carcinoma of the scalp: Efficacy of a chemotherapy schedule with methotrexate and bleomycin'. Together they form a unique fingerprint.

  • Cite this